Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival

Por Kuş, Tülay, Aktaş, Gökmen
Publicado no Turk J Urol (2017)

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

Por Kus, Tulay, Aktas, Gokmen, Sevinc, Alper, Kalender, Mehmet Emin, Camci, Celaletdin
Publicado no Onco Targets Ther (2015)

Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer

Por KUS, TULAY, AKTAS, GOKMEN, SEVINC, ALPER, OKTAY, CEMIL, KALENDER, MEHMET EMIN, CAMCI, CELALETDIN
Publicado no Mol Clin Oncol (2016)

Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literature review

Por KUS, TULAY, AKTAS, GOKMEN, KALENDER, MEHMET EMIN, SARI, IBRAHIM, ULKER, ESRA, CAMCI, CELALETDIN
Publicado no Oncol Lett (2016)

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer pa...

Por Aktas, Gokmen, Kus, Tulay, Kalender, Mehmet Emin, Sevinc, Alper, Camci, Celaletdin, Kul, Seval
Publicado no Onco Targets Ther (2016)

Prognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

Por Kus, Tulay, Aktas, Gokmen, Sevinc, Alper, Kalender, Mehmet Emin, Yilmaz, Mustafa, Kul, Seval, Oztuzcu, Serdar, Oktay, Cemil, Camci, Celaletdin
Publicado no Onco Targets Ther (2015)

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

Por Kus, Tulay, Aktas, Gokmen, Kalender, Mehmet Emin, Demiryurek, Abdullah Tuncay, Ulasli, Mustafa, Oztuzcu, Serdar, Sevinc, Alper, Kul, Seval, Camci, Celaletdin
Publicado no Onco Targets Ther (2016)

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

Por Suner, Ali, Buyukhatipoglu, Hakan, Aktas, Gokmen, Kus, Tulay, Ulasli, Mustafa, Oztuzcu, Serdar, Kalender, Mehmet Emin, Sevinc, Alper, Kul, Seval, Camci, Celaletdin
Publicado no Onco Targets Ther (2016)